Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    February 23-23, 2022

    3rd Materials Chemistry Webinar

    London, UK
    February 23-23, 2022

    3rd Smart Materials Webinar

    London, UK
    February 23-23, 2022

    2nd Webinar on Materials Technology

    London, UK
    February 24-25, 2022

    International Conference on Material Science and Engineering

    Prague, Czech Republic
    March 08-09, 2022

    World Congress on Carbon and Advanced Energy Materials

    Auckland, Newzealand
    March 11-12, 2022

    Regenerative Medicine

    Montreal, Canada
    March 21-22, 2022

    8th International Conference on Smart Materials

    Montreal, Canada
    March 21-22, 2022

    MCS

    Vancouver, Canada
    May 25-26, 2022

    Advanced-Materials 2022

    Valencia, Spain
    July 19-20, 2022

    International Conference on Materials Processing

    Tokyo, Japan
    October 28-29, 2022

    2nd World Summit on Emerging Materials and Nanotechnology

    Amsterdam, Netherlands
    December 05-05, 2022

    World Summit on Sustainable Materials

    London, UK

    Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in